Camilla Jandus

Tenure-track Assistant Professor

University of Geneva

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Camilla Jandus is a Tenure-track Assistant Professor at the University of Geneva, Switzerland. Her research focuses on advanced cellular therapies in cancer, the immune response in chronic myeloid leukemia, and the role of innate lymphoid cells in various pathophysiological conditions. Recent publications include studies on engineered TCR-T cells, immune correlates in NSCLC patients, and the impact of persistent HIV infection on immune cell dynamics.

Articles (12)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Grégory Verdeil

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Camilla Jandus

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Engineered CD4 TCR-T Cells with Conserved High-Affinity TCRs Targeting NY-ESO-1 for Advanced Cellular Therapies in Cancer

Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine: Immune Correlates in Long-Term Survivors

Assessing the Impact of Persistent HIV Infection on Innate Lymphoid Cells Using In Vitro Models

IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia.

High-throughput spatiotemporal monitoring of single-cell secretions via plasmonic microwell arrays.

Dendritic cells direct circadian anti-tumour immune responses.

Dampening of cytotoxic innate lymphoid cells: A new tumour immune escape mechanism in B cell non-Hodgkin's lymphoma.

Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et).

Gliadin-reactive vitamin D-sensitive proinflammatory ILCPs are enriched in celiac patients.

Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer.

The Era of Cytotoxic CD4 T Cells.

c-Maf enforces cytokine production and promotes memory-like responses in mouse and human type 2 innate lymphoid cells.

Collaborators (11)

Grégory Verdeil

Nathalie Arhel

Olivier Michielin

Daniel E. Speiser

Christoph Scheiermann

Mara Cenerenti

Sébastien Nisole

David Gfeller

Jean Villard

stephanie hugues

Mikael J. Pittet

Make your next move.